Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

400%

4 of 1 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03936699Not ApplicableCompleted

ELIRA 2: Safety and Effectiveness of TENS Assisted Weight Loss and Appetite Suppression

Role: lead

NCT03299881Not ApplicableTerminated

Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss

Role: lead

NCT03261531Not ApplicableTerminated

Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity

Role: collaborator

NCT03316105Not ApplicableTerminated

Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers

Role: collaborator

All 4 trials loaded